References
- Alsever JB, Ainslie RB. A new method for the preparation of dilute blood plasma and the operation of a complete transfusion service. New York State J Med 1941;41:126.
- Grohskopf LA, Roth VR, Feikin DR, et al. Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 2001;344:1491–7.
- Ramirez-Arcos S, Goldman M, Blajchman MA. Bacterial contamination. In: M. Popovsky, ed.AABB transfusion reactions. 3rd ed. Arlington, VA: American Association of Blood Banks, 2007:163– 206.
- Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005;18: 195–204.
- Roth VR,Arduino MJ, Nobiletti J, et al.Transfusion-related sepsis due to Serratia liquefaciens in the United States.Transfusion 2000;40:931–5.
- Labbate M, Queck SY, Koh KS, Rice SA, Givskov M, Kjelleberg S. Quorum sensing-controlled biofilm development in Serratia liquefaciens MG1. J Bacteriol 2004;186:692–8.
- Adegbola RA,Old DC.New fimbrial hemagglutinin in Serratia species.Infect Immun 1982;38:306–15.
- National Committee for Clinical Laboratory Standards M100–S12, 2002;22(1).
- Bahrani-Mougeot FK,Buckles EL,Lockatell CV,et al. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 2002;45:1079–93.
- http://www.fda.gov/cber/recalls/gamals012505.htm. Accessed on July 31, 2007.
- Nichols WA, Clegg S, Brown MR. Characterization of the type 1 fimbrial subunit gene (fimA) of Serratia marcescens. Mol Microbiol 1990;4: 2119–26.